🔗 Permalink

Inventor profile of:

Shannon E. Boye

City:

Gainesville, Florida

Country:

United States

Published Applications:

Last publication date:

2025-12-18

Top Assignees for applications by Shannon E. Boye

The entities that hold a legal rights for patent applications filed by inventor Boye Shannon E.:

University of Florida Research Foundation, Incorporated 17 Gainesville, FL United States
THE UAB RESEARCH FOUNDATION 4 Birmingham, AL United States
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 3 Gainesville, FL United States
EDITAS MEDICINE, INC. 1 Cambridge, MA United States

Recent patent applications by Boye Shannon E.

Shannon E. Boye from Gainesville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-18

US20250381298A1

Human necessities

DUAL AAV-MYO7A VECTORS WITH IMPROVED SAFETY FOR THE TREATMENT OF USH1B

#2 | 2024-12-19

US20240415983A1

Human necessities

AAV-MEDIATED THERAPIES FOR VISION LOSS ASSOCIATED WITH FRIEDREICH’S ATAXIA

#3 | 2023-08-24

US20230265455A1

Chemistry; metallurgy

IMPROVED AAV-MEDIATED X-LINKED RETINOSCHISIS THERAPIES

#4 | 2023-05-18

US20230149565A1

Human necessities

DUAL AAV-MYO7A VECTORS WITH IMPROVED SAFETY FOR THE TREATMENT OF USH1B

#5 | 2022-08-25

US20220267383A1

Chemistry; metallurgy

Modified AAV capsid proteins and uses thereof

#6 | 2022-06-16

US20220186260A1

Chemistry; metallurgy

RAAV-GUANYLATE CYCLASE COMPOSITIONS AND METHODS FOR TREATING LEBER'S CONGENITAL AMAUROSIS-1 (LCA1)

#7 | 2022-05-05

US20220133909A1

Human necessities

HIGHLY EFFICIENT TRANSDUCTION AND LATERAL SPREAD IN THE RETINA BY A NOVEL AAV VIRUS ENHANCED BY RATIONAL DESIGN

#8 | 2022-03-03

US20220062325A1

Human necessities

Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid

#9 | 2021-05-06

US20210130421A1

Chemistry; metallurgy

DUAL-AAV VECTOR-BASED SYSTEMS AND METHODS FOR DELIVERING OVERSIZED GENES TO MAMMALIAN CELLS

#10 | 2021-03-04

US20210061863A1

Chemistry; metallurgy

Modified AAV capsid proteins and uses thereof

#11 | 2020-12-31

US20200405744A1

Human necessities

Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid

#12 | 2020-11-05

US20200345865A1

Human necessities

Methods and compositions for treating cone-rod retinal dystrophy

#13 | 2020-10-22

US20200330611A1

Human necessities

METHODOLOGY FOR IDENTIFYING GENE DELIVERY VECTORS WITH RETINAL CELL SPECIFICITY IN NON-HUMAN PRIMATE

#14 | 2020-01-02

US20200002386A1

Chemistry; metallurgy

Modified AAV capsid proteins and uses thereof

#15 | 2019-05-23

US20190153050A1

Chemistry; metallurgy

Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells

#16 | 2018-04-12

US20180100165A1

Chemistry; metallurgy

RAAV-GUANYLATE CYCLASE COMPOSITIONS AND METHODS FOR TREATING LEBER'S CONGENITAL AMAUROSIS-1 (LCA1)

#17 | 2018-03-01

US20180057840A1

Chemistry; metallurgy

rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes

#18 | 2017-01-12

US20170007720A1

Human necessities

METHODS AND COMPOSITIONS FOR GENE DELIVERY TO ON BIPOLAR CELLS

#19 | 2016-12-22

US20160369299A1

Chemistry; metallurgy

rAAV vectors and methods for transduction of photoreceptors and RPE cells

InventorID:

1742740 ⎘